NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

40 hedge funds and large institutions have $10.7M invested in NeuBase Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

4% less call options, than puts

Call options by funds: $140K | Put options by funds: $146K

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$140K
Puts
$146K
Net Calls
Net Calls Change

Top Buyers

1
+$936K
2
+$487K
3
+$429K
4
CC
Cannell & Co
New York
+$370K
5
Northern Trust
Northern Trust
Illinois
+$156K

Top Sellers

1
-$110K
2
-$45.5K
3
-$31.3K
4
VF
Virtu Financial
New York
-$24K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$23.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$22K
27
$20K
28
$20K
29
$19K
30
$19K
31
$14K
32
$13K
33
$7K
34
$7K
35
$5K
36
$4K
37
$3K
38
$2K
39
$1K
40
$1K
41
–
42
–
43
–
44
–
45
–
46
–
1
2